Earlier this summer, President Biden announced that his administration would spend $42 billion through the Broadband Equity Access and Deployment (BEAD) program to ensure that “every person in America” had internet access by 2030. And, of course, there are some obvious stocks that will benefit from the broadband plan.  “It’s the biggest investment in high-speed
0 Comments
After a strong first seven months of 2023, is it too late to buy Palantir Technologies (NYSE:PLTR) stock? Definitely not, as Palantir Technologies is a consistent winner in the areas of data analytics and artificial intelligence (AI) technology. The company has even been compared to a well-known sports star, and Palantir fully deserves this accolade. Palantir
0 Comments
It’s been a difficult year for many investors to digest. Despite higher interest rates, the economy looks strong, with employment figures continuing to remain robust. In fact, unemployment levels are near historic lows, suggesting the bear market that took place last year perhaps shouldn’t have happened. That said, there are clear reasons for investors to
0 Comments
As the economy normalizes, the housing sector thrives, offering investors prolonged value growth. The article contains three homebuilder stocks that stand out in the market. These companies have not only weathered the adversities of fluctuating interest rates, inflation, and housing demands but have emerged stronger. It showcases strategies that tap into the pulse of the
0 Comments
Market conditions are not always the same. During bear markets, the objective of investors should be to preserve capital and ensure returns that beat inflation. However, when market sentiments are positive, the focus should be on maximizing returns. Of course, this does not imply that the portfolio should be entirely focused on growth stocks. However,
0 Comments
In 2014, Massachusetts-based T2 Biosystems (NASDAQ:TTOO) went public at $11 per share. Expectations were high for the young startup. Its sepsis-detecting products targeted a $20.3 billion industry, and T2’s Magnetic Resonance Platform (T2MR) was potentially game-changing. Shares would quickly rise to a pre-split $23. The product, however, would prove a dud. In 2020, most of
0 Comments